Jagsonpal Pharmaceuticals Ltd
NSE:JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd
NSE:JAGSNPHARM
Price:
174.07
INR
0.33%
Market Cap:
₹11.6B
Relative Value
The Relative Value of one
JAGSNPHARM
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 174.07 INR,
Jagsonpal Pharmaceuticals Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JAGSNPHARM Relative Value
HIDDEN
Multiples Across Competitors
JAGSNPHARM Competitors Multiples
Jagsonpal Pharmaceuticals Ltd Competitors
Jagsonpal Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Jagsonpal Pharmaceuticals Ltd
NSE:JAGSNPHARM
|
11.6B INR | 4.1 | 28.4 | 18.1 | 21.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
983.7B USD | 15.1 | 47.7 | 32.1 | 34.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.2B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
289.4B CHF | 4.7 | 31 | 13.1 | 15.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.5 | 31.6 | 17.4 | 24.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
244.8B CHF | 5.6 | 22.5 | 13.9 | 17.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.4 | 9.8 | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.3B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
